| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 43 | 2021 | 442 | 2.690 |
Why?
|
| Parathyroid Neoplasms | 16 | 2016 | 60 | 1.630 |
Why?
|
| Parathyroidectomy | 17 | 2019 | 79 | 1.500 |
Why?
|
| Hyperparathyroidism, Primary | 6 | 2019 | 46 | 1.210 |
Why?
|
| Parathyroid Hormone | 25 | 2019 | 227 | 1.110 |
Why?
|
| Adenoma | 15 | 2015 | 258 | 1.070 |
Why?
|
| Carcinoma, Papillary | 14 | 2017 | 159 | 1.050 |
Why?
|
| Hyperparathyroidism | 21 | 2002 | 65 | 1.040 |
Why?
|
| Streptococcus pyogenes | 14 | 2003 | 35 | 0.980 |
Why?
|
| Carcinoma | 17 | 2015 | 439 | 0.870 |
Why?
|
| Thyroidectomy | 24 | 2021 | 173 | 0.860 |
Why?
|
| Calcium | 41 | 2016 | 1176 | 0.760 |
Why?
|
| Genes, ras | 7 | 1997 | 97 | 0.710 |
Why?
|
| Pancreatic Neoplasms | 17 | 2020 | 715 | 0.660 |
Why?
|
| Streptococcal Infections | 14 | 2003 | 56 | 0.660 |
Why?
|
| Hypocalcemia | 16 | 2018 | 43 | 0.620 |
Why?
|
| Thyroid Gland | 20 | 2017 | 280 | 0.610 |
Why?
|
| Hyperparathyroidism, Secondary | 6 | 2018 | 71 | 0.570 |
Why?
|
| Parathyroid Glands | 22 | 2014 | 75 | 0.550 |
Why?
|
| Adenocarcinoma, Follicular | 7 | 2017 | 57 | 0.520 |
Why?
|
| Adenoma, Islet Cell | 14 | 1993 | 28 | 0.490 |
Why?
|
| Recurrent Laryngeal Nerve | 2 | 2009 | 11 | 0.480 |
Why?
|
| Neoplasms, Radiation-Induced | 5 | 2016 | 96 | 0.460 |
Why?
|
| Male | 131 | 2021 | 44557 | 0.460 |
Why?
|
| Female | 129 | 2021 | 48702 | 0.460 |
Why?
|
| Adult | 107 | 2018 | 27918 | 0.450 |
Why?
|
| Humans | 183 | 2021 | 93515 | 0.450 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2014 | 17 | 0.440 |
Why?
|
| Middle Aged | 93 | 2020 | 27573 | 0.420 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 2014 | 14 | 0.400 |
Why?
|
| Pharyngitis | 5 | 2001 | 15 | 0.380 |
Why?
|
| Radiopharmaceuticals | 4 | 2014 | 203 | 0.370 |
Why?
|
| Muscle Weakness | 2 | 2012 | 67 | 0.340 |
Why?
|
| Aged | 65 | 2020 | 20434 | 0.340 |
Why?
|
| Penicillin V | 3 | 2001 | 3 | 0.340 |
Why?
|
| Quality of Life | 7 | 2020 | 1780 | 0.330 |
Why?
|
| Thyroid Nodule | 3 | 2017 | 60 | 0.330 |
Why?
|
| Point Mutation | 3 | 1997 | 238 | 0.320 |
Why?
|
| Hypercalcemia | 5 | 2008 | 60 | 0.320 |
Why?
|
| Carcinoid Tumor | 7 | 1997 | 45 | 0.310 |
Why?
|
| Adrenal Gland Neoplasms | 6 | 2016 | 83 | 0.310 |
Why?
|
| Graves Disease | 11 | 1997 | 36 | 0.300 |
Why?
|
| Zollinger-Ellison Syndrome | 9 | 1990 | 10 | 0.300 |
Why?
|
| Adolescent | 42 | 2021 | 9606 | 0.300 |
Why?
|
| Medical Illustration | 1 | 2009 | 16 | 0.290 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 1917 | 0.290 |
Why?
|
| Dissection | 1 | 2009 | 45 | 0.290 |
Why?
|
| Penicillin G Benzathine | 3 | 2001 | 6 | 0.290 |
Why?
|
| Intestinal Neoplasms | 4 | 2020 | 68 | 0.280 |
Why?
|
| Kidney Failure, Chronic | 5 | 2014 | 429 | 0.280 |
Why?
|
| Retrospective Studies | 25 | 2020 | 10164 | 0.280 |
Why?
|
| Child | 36 | 2021 | 7355 | 0.280 |
Why?
|
| Familial Mediterranean Fever | 1 | 2007 | 4 | 0.260 |
Why?
|
| Adenocarcinoma | 6 | 2017 | 1173 | 0.260 |
Why?
|
| Postoperative Complications | 12 | 2020 | 2562 | 0.260 |
Why?
|
| Muscular Diseases | 1 | 2007 | 67 | 0.250 |
Why?
|
| Incidence | 15 | 2016 | 1701 | 0.250 |
Why?
|
| Fever | 1 | 2007 | 122 | 0.240 |
Why?
|
| Cancer Survivors | 2 | 2018 | 88 | 0.240 |
Why?
|
| Hypoglycemia | 4 | 2001 | 113 | 0.240 |
Why?
|
| Follow-Up Studies | 22 | 2016 | 3830 | 0.230 |
Why?
|
| Thyroiditis | 3 | 2002 | 10 | 0.230 |
Why?
|
| Schizophrenia | 2 | 1999 | 529 | 0.220 |
Why?
|
| Survivors | 2 | 2016 | 204 | 0.210 |
Why?
|
| Lymphatic Metastasis | 9 | 2017 | 504 | 0.210 |
Why?
|
| Cohort Studies | 8 | 2020 | 3054 | 0.210 |
Why?
|
| Fatigue | 2 | 2012 | 181 | 0.210 |
Why?
|
| Schizophrenic Psychology | 3 | 2000 | 141 | 0.210 |
Why?
|
| Terminology as Topic | 2 | 2015 | 218 | 0.200 |
Why?
|
| Rheumatic Fever | 4 | 1998 | 12 | 0.200 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 2 | 2016 | 17 | 0.200 |
Why?
|
| Calcitonin | 15 | 1984 | 40 | 0.200 |
Why?
|
| Survival Rate | 12 | 2016 | 1948 | 0.200 |
Why?
|
| Hypoparathyroidism | 2 | 2002 | 26 | 0.200 |
Why?
|
| Horner Syndrome | 1 | 2002 | 2 | 0.190 |
Why?
|
| Precancerous Conditions | 2 | 1994 | 205 | 0.190 |
Why?
|
| Nerve Compression Syndromes | 1 | 2002 | 19 | 0.190 |
Why?
|
| Age Factors | 17 | 2016 | 1906 | 0.180 |
Why?
|
| Pheochromocytoma | 7 | 2010 | 53 | 0.180 |
Why?
|
| Penicillins | 2 | 2001 | 24 | 0.180 |
Why?
|
| Ultrasonography | 5 | 2017 | 702 | 0.180 |
Why?
|
| Gastrins | 11 | 1977 | 15 | 0.180 |
Why?
|
| Cognition Disorders | 2 | 2005 | 236 | 0.180 |
Why?
|
| Recurrence | 7 | 2014 | 1190 | 0.180 |
Why?
|
| Carrier State | 1 | 2001 | 40 | 0.170 |
Why?
|
| Deoxyribonucleases | 2 | 1998 | 27 | 0.170 |
Why?
|
| Immunoassay | 2 | 2019 | 99 | 0.170 |
Why?
|
| Liver Neoplasms | 2 | 2007 | 776 | 0.170 |
Why?
|
| SEER Program | 7 | 2016 | 235 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2001 | 45 | 0.170 |
Why?
|
| Preoperative Care | 4 | 2018 | 406 | 0.170 |
Why?
|
| Child, Preschool | 23 | 2001 | 3829 | 0.170 |
Why?
|
| Awareness | 2 | 1999 | 89 | 0.170 |
Why?
|
| Drug Resistance, Microbial | 3 | 2001 | 62 | 0.170 |
Why?
|
| Pancreatic Diseases | 1 | 2001 | 58 | 0.170 |
Why?
|
| Mutation | 5 | 2008 | 4272 | 0.170 |
Why?
|
| Endocrine System Diseases | 2 | 1999 | 24 | 0.160 |
Why?
|
| Health Status | 3 | 2015 | 377 | 0.160 |
Why?
|
| Pancreatectomy | 2 | 2001 | 168 | 0.160 |
Why?
|
| T-Lymphocytes | 7 | 1997 | 1275 | 0.160 |
Why?
|
| Insulinoma | 4 | 1990 | 38 | 0.160 |
Why?
|
| Interpersonal Relations | 2 | 2000 | 177 | 0.160 |
Why?
|
| Hashimoto Disease | 1 | 2020 | 11 | 0.160 |
Why?
|
| Coordination Complexes | 1 | 2020 | 20 | 0.160 |
Why?
|
| Octreotide | 1 | 2020 | 29 | 0.160 |
Why?
|
| History, 19th Century | 3 | 2009 | 56 | 0.160 |
Why?
|
| Antibodies | 3 | 1998 | 348 | 0.160 |
Why?
|
| Receptors, Thyrotropin | 6 | 1997 | 48 | 0.160 |
Why?
|
| Psychometrics | 3 | 2017 | 337 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2015 | 624 | 0.150 |
Why?
|
| Time Factors | 21 | 2016 | 5410 | 0.150 |
Why?
|
| DNA, Neoplasm | 2 | 1992 | 266 | 0.150 |
Why?
|
| Hormone Replacement Therapy | 1 | 2020 | 93 | 0.150 |
Why?
|
| Hypertension | 3 | 2018 | 757 | 0.150 |
Why?
|
| Clinical Chemistry Tests | 1 | 2019 | 11 | 0.150 |
Why?
|
| Physicians | 2 | 2018 | 682 | 0.150 |
Why?
|
| Calcium Gluconate | 1 | 2018 | 4 | 0.150 |
Why?
|
| Hyperaldosteronism | 1 | 2018 | 13 | 0.140 |
Why?
|
| Chicago | 7 | 2016 | 1464 | 0.140 |
Why?
|
| Prognosis | 18 | 2016 | 3911 | 0.140 |
Why?
|
| History, 20th Century | 3 | 2009 | 314 | 0.140 |
Why?
|
| Rare Diseases | 2 | 2016 | 71 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2016 | 1448 | 0.140 |
Why?
|
| Duodenal Neoplasms | 3 | 1997 | 21 | 0.140 |
Why?
|
| United States | 15 | 2020 | 7622 | 0.140 |
Why?
|
| Streptolysins | 1 | 1998 | 5 | 0.140 |
Why?
|
| Neuroendocrine Tumors | 1 | 2020 | 136 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2000 | 243 | 0.130 |
Why?
|
| Islets of Langerhans | 1 | 2001 | 557 | 0.130 |
Why?
|
| Calcitriol | 1 | 2018 | 173 | 0.130 |
Why?
|
| Hepatitis C | 1 | 2000 | 182 | 0.130 |
Why?
|
| Sensitivity and Specificity | 7 | 2014 | 1922 | 0.130 |
Why?
|
| Personality | 1 | 1999 | 140 | 0.130 |
Why?
|
| Aged, 80 and over | 15 | 2016 | 7061 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 492 | 0.130 |
Why?
|
| Postoperative Care | 1 | 2018 | 235 | 0.130 |
Why?
|
| Anemia | 3 | 1997 | 134 | 0.130 |
Why?
|
| Social Perception | 1 | 2018 | 92 | 0.130 |
Why?
|
| Biopsy | 6 | 2002 | 1175 | 0.130 |
Why?
|
| Intraoperative Complications | 2 | 2016 | 195 | 0.130 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 308 | 0.130 |
Why?
|
| Radionuclide Imaging | 7 | 2014 | 189 | 0.130 |
Why?
|
| Treatment Outcome | 10 | 2020 | 9099 | 0.120 |
Why?
|
| Travel | 1 | 2017 | 73 | 0.120 |
Why?
|
| Electrosurgery | 1 | 2016 | 10 | 0.120 |
Why?
|
| Ultrasonic Surgical Procedures | 1 | 2016 | 6 | 0.120 |
Why?
|
| Respiratory Tract Diseases | 1 | 1996 | 45 | 0.120 |
Why?
|
| Vipoma | 2 | 1986 | 5 | 0.120 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2010 | 27 | 0.120 |
Why?
|
| Stomach | 4 | 1977 | 113 | 0.120 |
Why?
|
| Medical Errors | 1 | 2016 | 94 | 0.120 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 131 | 0.120 |
Why?
|
| Intestine, Small | 2 | 1997 | 310 | 0.110 |
Why?
|
| Gastric Bypass | 1 | 2016 | 114 | 0.110 |
Why?
|
| Acute Disease | 6 | 2002 | 841 | 0.110 |
Why?
|
| Epigenomics | 1 | 2016 | 109 | 0.110 |
Why?
|
| Biological Assay | 2 | 2014 | 82 | 0.110 |
Why?
|
| Age of Onset | 4 | 2015 | 342 | 0.110 |
Why?
|
| Mass Screening | 2 | 2018 | 696 | 0.110 |
Why?
|
| Cytokines | 3 | 1997 | 863 | 0.110 |
Why?
|
| Antibody Formation | 2 | 1994 | 169 | 0.110 |
Why?
|
| Spirituality | 1 | 2015 | 88 | 0.110 |
Why?
|
| Hyperostosis Frontalis Interna | 1 | 2014 | 3 | 0.110 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 1994 | 6 | 0.110 |
Why?
|
| Military Personnel | 1 | 1996 | 104 | 0.110 |
Why?
|
| Thyroid Diseases | 3 | 1997 | 106 | 0.110 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 1994 | 21 | 0.110 |
Why?
|
| Neoplasm Staging | 7 | 2020 | 2017 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 244 | 0.100 |
Why?
|
| Young Adult | 6 | 2016 | 6930 | 0.100 |
Why?
|
| Hominidae | 1 | 1994 | 106 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 474 | 0.100 |
Why?
|
| Social Behavior | 1 | 2015 | 307 | 0.100 |
Why?
|
| Primates | 1 | 1994 | 157 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 1998 | 1395 | 0.100 |
Why?
|
| Sex Factors | 8 | 2015 | 1105 | 0.090 |
Why?
|
| Antigens, CD | 1 | 1994 | 476 | 0.090 |
Why?
|
| Rectal Neoplasms | 3 | 2001 | 132 | 0.090 |
Why?
|
| Liver | 2 | 2016 | 1210 | 0.090 |
Why?
|
| Adrenal Gland Diseases | 1 | 1991 | 10 | 0.090 |
Why?
|
| Bronchogenic Cyst | 1 | 1991 | 5 | 0.090 |
Why?
|
| Bacterial Proteins | 5 | 1999 | 878 | 0.090 |
Why?
|
| Reference Values | 5 | 2016 | 608 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2012 | 143 | 0.090 |
Why?
|
| Gastric Juice | 7 | 1977 | 15 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2016 | 697 | 0.090 |
Why?
|
| Adrenalectomy | 4 | 2006 | 44 | 0.080 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 1713 | 0.080 |
Why?
|
| Breast Neoplasms | 5 | 2016 | 3110 | 0.080 |
Why?
|
| Intraoperative Period | 2 | 2019 | 94 | 0.080 |
Why?
|
| History, 18th Century | 2 | 2009 | 20 | 0.080 |
Why?
|
| Molecular Sequence Data | 7 | 2008 | 2910 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 6 | 2000 | 894 | 0.080 |
Why?
|
| Gastrinoma | 1 | 1990 | 2 | 0.080 |
Why?
|
| Syndrome | 3 | 2007 | 437 | 0.080 |
Why?
|
| Autoimmune Diseases | 3 | 1997 | 255 | 0.080 |
Why?
|
| Disease Outbreaks | 2 | 1991 | 150 | 0.080 |
Why?
|
| Base Sequence | 6 | 2008 | 2220 | 0.080 |
Why?
|
| Adenoids | 2 | 2009 | 10 | 0.080 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2015 | 107 | 0.080 |
Why?
|
| Multiple Endocrine Neoplasia | 2 | 1990 | 7 | 0.080 |
Why?
|
| Palatine Tonsil | 2 | 2009 | 32 | 0.080 |
Why?
|
| Malpractice | 1 | 2010 | 47 | 0.080 |
Why?
|
| Nuclear Reactors | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cushing Syndrome | 4 | 2006 | 25 | 0.080 |
Why?
|
| Prospective Studies | 8 | 2015 | 4560 | 0.080 |
Why?
|
| Reoperation | 4 | 2002 | 702 | 0.080 |
Why?
|
| Penicillin G | 1 | 1989 | 4 | 0.080 |
Why?
|
| Kidney Calculi | 1 | 2012 | 343 | 0.080 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 2 | 2004 | 6 | 0.080 |
Why?
|
| Monitoring, Physiologic | 2 | 2002 | 262 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 1993 | 579 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 5 | 2001 | 836 | 0.070 |
Why?
|
| History, 16th Century | 1 | 2009 | 8 | 0.070 |
Why?
|
| Pregnancy Complications | 3 | 1984 | 352 | 0.070 |
Why?
|
| History, Ancient | 1 | 2009 | 80 | 0.070 |
Why?
|
| Alkalosis | 3 | 1974 | 10 | 0.070 |
Why?
|
| Serotyping | 3 | 2003 | 28 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2014 | 822 | 0.070 |
Why?
|
| Endocarditis, Bacterial | 4 | 1984 | 37 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 401 | 0.070 |
Why?
|
| Case-Control Studies | 4 | 2016 | 1931 | 0.070 |
Why?
|
| Insulin | 7 | 1987 | 1185 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2000 | 502 | 0.070 |
Why?
|
| Positron-Emission Tomography | 3 | 2020 | 349 | 0.070 |
Why?
|
| Infant | 14 | 1997 | 3220 | 0.070 |
Why?
|
| Depression | 1 | 2012 | 544 | 0.070 |
Why?
|
| Animals | 32 | 2016 | 28155 | 0.070 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2008 | 48 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1762 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2008 | 75 | 0.070 |
Why?
|
| Vocal Cord Paralysis | 2 | 2010 | 25 | 0.070 |
Why?
|
| Pyrin | 1 | 2007 | 1 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1660 | 0.060 |
Why?
|
| Chronobiology Phenomena | 1 | 2007 | 4 | 0.060 |
Why?
|
| Combined Modality Therapy | 7 | 2001 | 1723 | 0.060 |
Why?
|
| Parathyroid Diseases | 2 | 1983 | 9 | 0.060 |
Why?
|
| Injections, Intramuscular | 2 | 2001 | 63 | 0.060 |
Why?
|
| Pre-Eclampsia | 1 | 2010 | 261 | 0.060 |
Why?
|
| Swine | 7 | 2016 | 588 | 0.060 |
Why?
|
| Intraocular Pressure | 1 | 2007 | 62 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2001 | 512 | 0.060 |
Why?
|
| Hyperplasia | 5 | 1992 | 147 | 0.060 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2006 | 11 | 0.060 |
Why?
|
| Risk Factors | 5 | 2016 | 5899 | 0.060 |
Why?
|
| Bacterial Typing Techniques | 2 | 1999 | 28 | 0.060 |
Why?
|
| Dementia | 2 | 2005 | 214 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2007 | 223 | 0.060 |
Why?
|
| Glucagonoma | 1 | 1986 | 1 | 0.060 |
Why?
|
| Somatostatinoma | 1 | 1986 | 1 | 0.060 |
Why?
|
| Pancreatic Polypeptide | 1 | 1986 | 9 | 0.060 |
Why?
|
| Neuropsychological Tests | 3 | 2005 | 543 | 0.060 |
Why?
|
| Codon | 2 | 1997 | 116 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 1999 | 56 | 0.060 |
Why?
|
| Goiter | 2 | 2002 | 45 | 0.060 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 2802 | 0.060 |
Why?
|
| Radioimmunoassay | 8 | 1974 | 144 | 0.060 |
Why?
|
| Pancreas | 2 | 1986 | 258 | 0.060 |
Why?
|
| Ferric Compounds | 2 | 1996 | 41 | 0.060 |
Why?
|
| Iodine Radioisotopes | 6 | 1995 | 137 | 0.060 |
Why?
|
| Antigens, Bacterial | 2 | 1999 | 135 | 0.060 |
Why?
|
| Behavioral Medicine | 1 | 2005 | 5 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2005 | 2715 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 1996 | 470 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2007 | 281 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 1987 | 603 | 0.060 |
Why?
|
| Palliative Care | 1 | 2007 | 269 | 0.060 |
Why?
|
| Neoplasms | 3 | 2016 | 3169 | 0.060 |
Why?
|
| Renal Dialysis | 4 | 2014 | 350 | 0.060 |
Why?
|
| Blood Glucose | 5 | 1987 | 867 | 0.060 |
Why?
|
| Cholecystokinin | 3 | 1977 | 15 | 0.060 |
Why?
|
| Survival Analysis | 3 | 2021 | 1524 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2001 | 314 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 1991 | 754 | 0.050 |
Why?
|
| Heart Rate | 2 | 2007 | 505 | 0.050 |
Why?
|
| Pain | 1 | 2007 | 414 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2484 | 0.050 |
Why?
|
| Catecholamines | 1 | 2004 | 91 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 285 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2005 | 171 | 0.050 |
Why?
|
| Adenoma, Oxyphilic | 2 | 2013 | 37 | 0.050 |
Why?
|
| Vancomycin | 1 | 1984 | 75 | 0.050 |
Why?
|
| Comorbidity | 2 | 2017 | 1007 | 0.050 |
Why?
|
| Sepsis | 3 | 1991 | 388 | 0.050 |
Why?
|
| Blood Pressure | 3 | 2007 | 896 | 0.050 |
Why?
|
| Sheep | 7 | 1984 | 203 | 0.050 |
Why?
|
| Aging | 2 | 2007 | 727 | 0.050 |
Why?
|
| Drug Administration Schedule | 2 | 2020 | 829 | 0.050 |
Why?
|
| Neurology | 1 | 2005 | 83 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1799 | 0.050 |
Why?
|
| Pharynx | 3 | 2003 | 44 | 0.050 |
Why?
|
| Hypokalemia | 2 | 2018 | 22 | 0.050 |
Why?
|
| Anal Canal | 2 | 2001 | 92 | 0.050 |
Why?
|
| Registries | 3 | 2021 | 990 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 2585 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2001 | 292 | 0.050 |
Why?
|
| Prevalence | 3 | 2015 | 1321 | 0.050 |
Why?
|
| Infant, Newborn | 7 | 1995 | 2479 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 1999 | 663 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2001 | 146 | 0.050 |
Why?
|
| Pregnancy | 7 | 2010 | 3147 | 0.050 |
Why?
|
| Administration, Oral | 3 | 2001 | 657 | 0.050 |
Why?
|
| Antibodies, Bacterial | 2 | 1997 | 103 | 0.050 |
Why?
|
| Leukemia, Lymphoid | 2 | 1981 | 48 | 0.050 |
Why?
|
| Neck Pain | 1 | 2002 | 48 | 0.050 |
Why?
|
| Neck Dissection | 2 | 2016 | 67 | 0.050 |
Why?
|
| Rats | 13 | 1980 | 4072 | 0.050 |
Why?
|
| Bradycardia | 1 | 2002 | 46 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2015 | 283 | 0.050 |
Why?
|
| Probability | 3 | 1999 | 355 | 0.050 |
Why?
|
| Acidosis | 2 | 1972 | 53 | 0.050 |
Why?
|
| Pentagastrin | 3 | 1979 | 4 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 1982 | 276 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 1984 | 286 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2004 | 291 | 0.040 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2001 | 8 | 0.040 |
Why?
|
| Fecal Incontinence | 1 | 2001 | 59 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2001 | 159 | 0.040 |
Why?
|
| Verapamil | 1 | 2001 | 32 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2001 | 67 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 876 | 0.040 |
Why?
|
| Regression Analysis | 3 | 2014 | 579 | 0.040 |
Why?
|
| Recombinant Proteins | 4 | 1996 | 988 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2001 | 118 | 0.040 |
Why?
|
| Wechsler Scales | 1 | 2000 | 17 | 0.040 |
Why?
|
| Educational Status | 2 | 2015 | 197 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2014 | 884 | 0.040 |
Why?
|
| Histamine | 3 | 1979 | 116 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 278 | 0.040 |
Why?
|
| Home Care Services, Hospital-Based | 1 | 2000 | 10 | 0.040 |
Why?
|
| Epitopes | 3 | 1996 | 254 | 0.040 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 394 | 0.040 |
Why?
|
| Lung Neoplasms | 4 | 1995 | 2365 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 1997 | 1264 | 0.040 |
Why?
|
| Proinsulin | 4 | 1987 | 123 | 0.040 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2001 | 115 | 0.040 |
Why?
|
| Ego | 1 | 2000 | 4 | 0.040 |
Why?
|
| Propensity Score | 1 | 2021 | 178 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2001 | 284 | 0.040 |
Why?
|
| Response Evaluation Criteria in Solid Tumors | 1 | 2020 | 60 | 0.040 |
Why?
|
| Streptococcus | 3 | 1989 | 8 | 0.040 |
Why?
|
| Object Attachment | 1 | 2000 | 20 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1998 | 367 | 0.040 |
Why?
|
| Hepatitis C Antibodies | 1 | 2000 | 8 | 0.040 |
Why?
|
| Adrenal Glands | 3 | 2004 | 74 | 0.040 |
Why?
|
| Leukemia | 2 | 1981 | 301 | 0.040 |
Why?
|
| Models, Economic | 1 | 2020 | 61 | 0.040 |
Why?
|
| Markov Chains | 1 | 2020 | 135 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2000 | 89 | 0.040 |
Why?
|
| Phosphorus | 6 | 1982 | 119 | 0.040 |
Why?
|
| Pancreas Transplantation | 1 | 2000 | 104 | 0.040 |
Why?
|
| Disease Progression | 2 | 2005 | 1531 | 0.040 |
Why?
|
| Ribonucleases | 1 | 2000 | 92 | 0.040 |
Why?
|
| Immunoglobulin G | 3 | 1997 | 464 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 1980 | 293 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 1980 | 128 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2020 | 156 | 0.040 |
Why?
|
| Carotid Body | 1 | 2002 | 241 | 0.040 |
Why?
|
| Gastrectomy | 6 | 1979 | 71 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2001 | 244 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2001 | 524 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2006 | 782 | 0.040 |
Why?
|
| Canada | 2 | 2015 | 194 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 1980 | 159 | 0.040 |
Why?
|
| Iodide Peroxidase | 2 | 1997 | 215 | 0.040 |
Why?
|
| Organometallic Compounds | 1 | 2020 | 139 | 0.040 |
Why?
|
| Shock, Septic | 2 | 1997 | 124 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2001 | 589 | 0.040 |
Why?
|
| Antithyroid Agents | 3 | 1995 | 23 | 0.040 |
Why?
|
| Thyroglobulin | 3 | 1995 | 59 | 0.040 |
Why?
|
| Personality Assessment | 1 | 1999 | 99 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2000 | 135 | 0.040 |
Why?
|
| Cause of Death | 1 | 2000 | 273 | 0.040 |
Why?
|
| Phosphates | 2 | 1970 | 165 | 0.040 |
Why?
|
| Secretin | 4 | 1979 | 6 | 0.040 |
Why?
|
| Lymph Node Excision | 2 | 2017 | 233 | 0.040 |
Why?
|
| Memory | 1 | 2000 | 227 | 0.040 |
Why?
|
| Injections, Intravenous | 5 | 1996 | 212 | 0.040 |
Why?
|
| Length of Stay | 2 | 2018 | 828 | 0.040 |
Why?
|
| Social Adjustment | 1 | 1998 | 47 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2000 | 306 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2016 | 2441 | 0.030 |
Why?
|
| Minnesota | 3 | 1991 | 50 | 0.030 |
Why?
|
| C-Peptide | 3 | 1987 | 184 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2008 | 3502 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 3 | 1973 | 34 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2000 | 497 | 0.030 |
Why?
|
| Neoplasm Metastasis | 4 | 1992 | 1061 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 1991 | 1546 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1995 | 194 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 1977 | 8 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 1170 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 1997 | 38 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2000 | 381 | 0.030 |
Why?
|
| Radiotherapy | 2 | 1976 | 320 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1993 | 36 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2018 | 236 | 0.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1997 | 149 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3476 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 1999 | 230 | 0.030 |
Why?
|
| Gastric Mucosa | 3 | 1977 | 70 | 0.030 |
Why?
|
| Prostaglandins | 3 | 1973 | 44 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 232 | 0.030 |
Why?
|
| Serotonin | 3 | 1973 | 209 | 0.030 |
Why?
|
| Medicare | 1 | 2020 | 455 | 0.030 |
Why?
|
| Hospitals, Military | 1 | 1996 | 3 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 1998 | 712 | 0.030 |
Why?
|
| Chlamydophila pneumoniae | 1 | 1996 | 13 | 0.030 |
Why?
|
| Intestinal Diseases | 1 | 1997 | 84 | 0.030 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 1996 | 9 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2018 | 347 | 0.030 |
Why?
|
| Body Temperature | 1 | 2016 | 131 | 0.030 |
Why?
|
| Plutonium | 1 | 1995 | 1 | 0.030 |
Why?
|
| Radioactive Fallout | 1 | 1995 | 1 | 0.030 |
Why?
|
| Spumavirus | 1 | 1995 | 1 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2020 | 1118 | 0.030 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 1996 | 22 | 0.030 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 219 | 0.030 |
Why?
|
| Myometrium | 1 | 1996 | 54 | 0.030 |
Why?
|
| Community Medicine | 1 | 1975 | 1 | 0.030 |
Why?
|
| Lymphocyte Transfusion | 1 | 1995 | 39 | 0.030 |
Why?
|
| Patient Admission | 1 | 1996 | 119 | 0.030 |
Why?
|
| Comprehensive Health Care | 1 | 1975 | 14 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 168 | 0.030 |
Why?
|
| Retroviridae Infections | 1 | 1995 | 43 | 0.030 |
Why?
|
| Video-Assisted Surgery | 1 | 2015 | 7 | 0.030 |
Why?
|
| Goiter, Substernal | 1 | 1975 | 3 | 0.030 |
Why?
|
| Autoimmunity | 1 | 1996 | 189 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 256 | 0.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 1996 | 204 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1995 | 158 | 0.030 |
Why?
|
| Finland | 1 | 2014 | 31 | 0.030 |
Why?
|
| Vena Cava, Superior | 1 | 1975 | 54 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2015 | 97 | 0.030 |
Why?
|
| Peptic Ulcer | 1 | 1974 | 18 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2015 | 129 | 0.030 |
Why?
|
| Pancreatitis | 1 | 1975 | 94 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2001 | 2303 | 0.030 |
Why?
|
| Thymectomy | 1 | 2014 | 32 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 1994 | 23 | 0.030 |
Why?
|
| Frozen Sections | 1 | 2014 | 50 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 484 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 413 | 0.030 |
Why?
|
| Communication | 1 | 2018 | 434 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 210 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1994 | 68 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 291 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 59 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 1994 | 80 | 0.030 |
Why?
|
| Global Health | 1 | 2016 | 208 | 0.030 |
Why?
|
| Papio | 1 | 1994 | 87 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 1996 | 337 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 1994 | 1133 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1994 | 113 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2005 | 228 | 0.030 |
Why?
|
| DNA Primers | 2 | 2008 | 531 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 114 | 0.030 |
Why?
|
| Autoradiography | 1 | 1993 | 53 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2000 | 870 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1979 | 506 | 0.030 |
Why?
|
| Rheumatic Heart Disease | 3 | 1998 | 28 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 1996 | 227 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 887 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 985 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 576 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1996 | 537 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2016 | 811 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 1243 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 660 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 481 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 154 | 0.020 |
Why?
|
| Pylorus | 1 | 1972 | 15 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 1994 | 203 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2016 | 548 | 0.020 |
Why?
|
| Diarrhea | 2 | 1971 | 179 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 775 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2013 | 159 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 1992 | 150 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 1994 | 448 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1053 | 0.020 |
Why?
|
| Retroperitoneal Space | 1 | 1991 | 42 | 0.020 |
Why?
|
| Endoscopy | 1 | 2015 | 366 | 0.020 |
Why?
|
| Body Weight | 2 | 1989 | 449 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2013 | 251 | 0.020 |
Why?
|
| Iron | 2 | 1996 | 174 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1994 | 688 | 0.020 |
Why?
|
| Prostatic Neoplasms | 2 | 1996 | 1775 | 0.020 |
Why?
|
| Jurisprudence | 1 | 2010 | 24 | 0.020 |
Why?
|
| Forecasting | 1 | 1991 | 293 | 0.020 |
Why?
|
| Pyoderma | 1 | 1970 | 3 | 0.020 |
Why?
|
| Adrenal Medulla | 1 | 1970 | 49 | 0.020 |
Why?
|
| Transplantation, Heterologous | 3 | 1997 | 371 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 2001 | 19 | 0.020 |
Why?
|
| Body Surface Area | 1 | 1989 | 36 | 0.020 |
Why?
|
| Pedigree | 2 | 2004 | 961 | 0.020 |
Why?
|
| Stomach Diseases | 1 | 1969 | 18 | 0.020 |
Why?
|
| Duodenal Diseases | 1 | 1969 | 25 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 1970 | 80 | 0.020 |
Why?
|
| Hormones | 1 | 1969 | 136 | 0.020 |
Why?
|
| Robotic Surgical Procedures | 1 | 2015 | 368 | 0.020 |
Why?
|
| Bicarbonates | 3 | 1974 | 58 | 0.020 |
Why?
|
| Random Allocation | 1 | 1989 | 307 | 0.020 |
Why?
|
| Lymphocyte Activation | 3 | 1996 | 797 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2008 | 141 | 0.020 |
Why?
|
| Receptors, Dopamine | 1 | 1988 | 32 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1974 | 493 | 0.020 |
Why?
|
| Gallbladder | 1 | 1968 | 32 | 0.020 |
Why?
|
| Ploidies | 1 | 1987 | 39 | 0.020 |
Why?
|
| Bile | 1 | 1968 | 60 | 0.020 |
Why?
|
| Dopamine Agents | 1 | 1988 | 32 | 0.020 |
Why?
|
| Clone Cells | 2 | 1998 | 219 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 361 | 0.020 |
Why?
|
| Benzazepines | 1 | 1988 | 65 | 0.020 |
Why?
|
| Exotoxins | 2 | 1997 | 21 | 0.020 |
Why?
|
| Nevada | 1 | 1987 | 3 | 0.020 |
Why?
|
| Utah | 1 | 1987 | 9 | 0.020 |
Why?
|
| Idaho | 1 | 1987 | 9 | 0.020 |
Why?
|
| Wyoming | 1 | 1987 | 7 | 0.020 |
Why?
|
| Supine Position | 1 | 2007 | 34 | 0.020 |
Why?
|
| Cell Line | 3 | 1995 | 2464 | 0.020 |
Why?
|
| Choristoma | 1 | 1987 | 59 | 0.020 |
Why?
|
| Posture | 1 | 2007 | 123 | 0.020 |
Why?
|
| Manometry | 2 | 2001 | 42 | 0.020 |
Why?
|
| Dopamine | 1 | 1988 | 276 | 0.020 |
Why?
|
| Glucaric Acid | 2 | 1996 | 5 | 0.010 |
Why?
|
| Mice, SCID | 2 | 1997 | 271 | 0.010 |
Why?
|
| Galactorrhea | 1 | 1986 | 6 | 0.010 |
Why?
|
| Portal System | 1 | 1966 | 13 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2010 | 1006 | 0.010 |
Why?
|
| Amenorrhea | 1 | 1986 | 27 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 1991 | 1847 | 0.010 |
Why?
|
| Sodium Chloride | 2 | 1977 | 84 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1986 | 88 | 0.010 |
Why?
|
| Erythropoietin | 2 | 1996 | 90 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2008 | 664 | 0.010 |
Why?
|
| Diethylstilbestrol | 1 | 1985 | 119 | 0.010 |
Why?
|
| Dental Plaque | 1 | 1984 | 2 | 0.010 |
Why?
|
| Metanephrine | 1 | 2004 | 6 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1987 | 176 | 0.010 |
Why?
|
| MMPI | 1 | 1964 | 10 | 0.010 |
Why?
|
| Iodine Isotopes | 2 | 1973 | 18 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2005 | 120 | 0.010 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2004 | 20 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1984 | 77 | 0.010 |
Why?
|
| Propylthiouracil | 2 | 1979 | 26 | 0.010 |
Why?
|
| Cats | 1 | 1984 | 285 | 0.010 |
Why?
|
| Labor, Obstetric | 1 | 2004 | 47 | 0.010 |
Why?
|
| Phenotype | 2 | 2001 | 2544 | 0.010 |
Why?
|
| Body Image | 1 | 1964 | 84 | 0.010 |
Why?
|
| Gluconates | 3 | 1975 | 14 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 157 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1117 | 0.010 |
Why?
|
| Magnesium | 2 | 1975 | 173 | 0.010 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 1984 | 72 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 1995 | 2495 | 0.010 |
Why?
|
| Rabbits | 1 | 1984 | 618 | 0.010 |
Why?
|
| Iran | 1 | 2003 | 17 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 75 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 174 | 0.010 |
Why?
|
| Duodenal Ulcer | 2 | 1973 | 11 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 206 | 0.010 |
Why?
|
| Methods | 1 | 1982 | 139 | 0.010 |
Why?
|
| Breast | 1 | 1964 | 294 | 0.010 |
Why?
|
| Echocardiography | 1 | 1987 | 745 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 2 | 1983 | 94 | 0.010 |
Why?
|
| Thyroid Function Tests | 1 | 1963 | 123 | 0.010 |
Why?
|
| Radiometry | 1 | 1963 | 60 | 0.010 |
Why?
|
| Technetium | 1 | 1982 | 22 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1741 | 0.010 |
Why?
|
| Maryland | 2 | 1981 | 45 | 0.010 |
Why?
|
| Hydrochloric Acid | 2 | 1972 | 11 | 0.010 |
Why?
|
| Kinetics | 1 | 1984 | 1492 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1982 | 88 | 0.010 |
Why?
|
| Mediastinal Neoplasms | 1 | 1982 | 43 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 2 | 1973 | 33 | 0.010 |
Why?
|
| Students | 1 | 2003 | 179 | 0.010 |
Why?
|
| Research | 1 | 1963 | 251 | 0.010 |
Why?
|
| Radiotherapy Dosage | 3 | 1994 | 472 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1983 | 270 | 0.010 |
Why?
|
| Erythromycin | 1 | 2001 | 10 | 0.010 |
Why?
|
| Chile | 1 | 2001 | 9 | 0.010 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2001 | 44 | 0.010 |
Why?
|
| Clindamycin | 1 | 2001 | 15 | 0.010 |
Why?
|
| Heart Defects, Congenital | 2 | 1979 | 367 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1963 | 246 | 0.010 |
Why?
|
| Psychoanalytic Interpretation | 1 | 2000 | 1 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1963 | 217 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 2000 | 58 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2000 | 86 | 0.010 |
Why?
|
| Portacaval Shunt, Surgical | 1 | 1980 | 8 | 0.010 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2000 | 64 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 767 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1979 | 46 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2000 | 112 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1987 | 1073 | 0.010 |
Why?
|
| Socioeconomic Factors | 2 | 1981 | 624 | 0.010 |
Why?
|
| Methimazole | 1 | 1979 | 13 | 0.010 |
Why?
|
| Leukemia, Radiation-Induced | 1 | 1979 | 13 | 0.010 |
Why?
|
| Veterans | 1 | 2000 | 99 | 0.010 |
Why?
|
| Propranolol | 1 | 1979 | 43 | 0.010 |
Why?
|
| Premedication | 1 | 1979 | 57 | 0.010 |
Why?
|
| Laboratories | 1 | 1999 | 46 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2000 | 165 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1963 | 455 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 298 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1979 | 100 | 0.010 |
Why?
|
| Depression, Chemical | 2 | 1974 | 25 | 0.010 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 1997 | 17 | 0.010 |
Why?
|
| Gallium Radioisotopes | 1 | 1977 | 20 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 1997 | 21 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2000 | 1014 | 0.010 |
Why?
|
| Pharyngeal Diseases | 1 | 1997 | 10 | 0.010 |
Why?
|
| Chimera | 1 | 1997 | 52 | 0.010 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1997 | 11 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2001 | 446 | 0.010 |
Why?
|
| Lymphotoxin-alpha | 1 | 1997 | 41 | 0.010 |
Why?
|
| North Carolina | 1 | 1997 | 56 | 0.010 |
Why?
|
| India | 1 | 1998 | 139 | 0.010 |
Why?
|
| Sodium | 2 | 1970 | 329 | 0.010 |
Why?
|
| Learning | 1 | 2000 | 293 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 409 | 0.010 |
Why?
|
| Soft Tissue Infections | 1 | 1997 | 27 | 0.010 |
Why?
|
| Patient Selection | 1 | 2001 | 690 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 1997 | 57 | 0.010 |
Why?
|
| Risk | 1 | 1979 | 657 | 0.010 |
Why?
|
| Autoantibodies | 2 | 1995 | 277 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1977 | 16 | 0.010 |
Why?
|
| Abscess | 1 | 1997 | 94 | 0.010 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 1977 | 11 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1997 | 224 | 0.010 |
Why?
|
| Epidemiologic Factors | 1 | 1997 | 5 | 0.010 |
Why?
|
| History, 17th Century | 1 | 1997 | 12 | 0.010 |
Why?
|
| Interleukins | 1 | 1997 | 133 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1998 | 220 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1998 | 469 | 0.010 |
Why?
|
| Superantigens | 1 | 1997 | 24 | 0.010 |
Why?
|
| Th1 Cells | 1 | 1997 | 167 | 0.010 |
Why?
|
| Office Visits | 1 | 1997 | 47 | 0.010 |
Why?
|
| Autoantigens | 1 | 1997 | 138 | 0.010 |
Why?
|
| Bacteremia | 1 | 1997 | 108 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1997 | 68 | 0.010 |
Why?
|
| Ferrous Compounds | 1 | 1996 | 18 | 0.010 |
Why?
|
| Calcium Chloride | 2 | 1975 | 11 | 0.010 |
Why?
|
| Glucose | 1 | 1979 | 692 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1996 | 171 | 0.010 |
Why?
|
| Micronesia | 1 | 1995 | 5 | 0.010 |
Why?
|
| Ferritins | 1 | 1996 | 28 | 0.010 |
Why?
|
| Body Burden | 1 | 1995 | 10 | 0.010 |
Why?
|
| Genes, gag | 1 | 1995 | 7 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1997 | 287 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1996 | 116 | 0.010 |
Why?
|
| DNA Probes | 1 | 1995 | 67 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1997 | 460 | 0.010 |
Why?
|
| Urinalysis | 1 | 1995 | 34 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1976 | 74 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1996 | 200 | 0.010 |
Why?
|
| Cattle | 1 | 1976 | 397 | 0.010 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 1995 | 5 | 0.010 |
Why?
|
| Radiation Effects | 1 | 1975 | 25 | 0.010 |
Why?
|
| Constriction | 1 | 1975 | 27 | 0.010 |
Why?
|
| Morbidity | 1 | 1995 | 162 | 0.010 |
Why?
|
| Glucagon | 1 | 1975 | 114 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1976 | 160 | 0.010 |
Why?
|
| Phlebography | 1 | 1975 | 68 | 0.010 |
Why?
|
| HLA-DQ Antigens | 1 | 1995 | 51 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 1995 | 229 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1974 | 117 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1995 | 234 | 0.010 |
Why?
|
| Leukocytes | 1 | 1995 | 210 | 0.010 |
Why?
|
| Neck | 1 | 1975 | 98 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1976 | 522 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1996 | 572 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 1234 | 0.010 |
Why?
|
| Neutrophils | 1 | 1976 | 324 | 0.010 |
Why?
|
| Genetic Testing | 1 | 1998 | 565 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1995 | 309 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1995 | 361 | 0.010 |
Why?
|
| Calcium Carbonate | 1 | 1973 | 4 | 0.010 |
Why?
|
| Monocytes | 1 | 1995 | 215 | 0.010 |
Why?
|
| Shock, Surgical | 1 | 1973 | 1 | 0.010 |
Why?
|
| Intestinal Absorption | 2 | 1973 | 125 | 0.010 |
Why?
|
| Cell Division | 1 | 1995 | 693 | 0.010 |
Why?
|
| Kallikreins | 1 | 1973 | 46 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1973 | 24 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1975 | 293 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1992 | 26 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1988 | 1914 | 0.010 |
Why?
|
| Mice | 2 | 1997 | 12269 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1972 | 22 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 110 | 0.010 |
Why?
|
| Anura | 2 | 1971 | 19 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 125 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1992 | 64 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1972 | 11 | 0.010 |
Why?
|
| Postoperative Period | 2 | 1983 | 315 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1973 | 238 | 0.010 |
Why?
|
| Malignant Carcinoid Syndrome | 1 | 1972 | 3 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1973 | 399 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1994 | 759 | 0.010 |
Why?
|
| Malabsorption Syndromes | 1 | 1972 | 21 | 0.010 |
Why?
|
| Reference Standards | 1 | 1992 | 146 | 0.010 |
Why?
|
| Intestines | 1 | 1975 | 432 | 0.010 |
Why?
|
| Veins | 1 | 1972 | 87 | 0.010 |
Why?
|
| Neurofibromatosis 1 | 1 | 1972 | 42 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1971 | 103 | 0.010 |
Why?
|
| Colorado | 1 | 1991 | 39 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 2012 | 0.010 |
Why?
|
| Ileum | 1 | 1972 | 167 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1972 | 122 | 0.010 |
Why?
|
| Salicylates | 1 | 1971 | 25 | 0.010 |
Why?
|
| Decision Making | 1 | 1996 | 674 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1972 | 149 | 0.010 |
Why?
|
| Adrenal Cortex | 1 | 1970 | 20 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1995 | 660 | 0.010 |
Why?
|
| Vitamin D | 1 | 1973 | 272 | 0.010 |
Why?
|
| Virulence | 1 | 1991 | 273 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1971 | 100 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1995 | 2850 | 0.000 |
Why?
|
| Anuria | 1 | 1970 | 6 | 0.000 |
Why?
|
| Blood Sedimentation | 1 | 1970 | 13 | 0.000 |
Why?
|
| Kidney | 1 | 1975 | 1111 | 0.000 |
Why?
|
| Bacteriuria | 1 | 1970 | 10 | 0.000 |
Why?
|
| Blood Cell Count | 1 | 1970 | 66 | 0.000 |
Why?
|
| Bone Development | 1 | 1970 | 38 | 0.000 |
Why?
|
| Indians, North American | 1 | 1970 | 48 | 0.000 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 181 | 0.000 |
Why?
|
| Proteinuria | 1 | 1970 | 69 | 0.000 |
Why?
|
| Edema | 1 | 1970 | 70 | 0.000 |
Why?
|
| Kidney Function Tests | 1 | 1970 | 115 | 0.000 |
Why?
|
| Desoxycorticosterone | 1 | 1969 | 18 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1973 | 713 | 0.000 |
Why?
|
| Hematuria | 1 | 1970 | 49 | 0.000 |
Why?
|
| Gastric Acidity Determination | 1 | 1969 | 2 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1970 | 191 | 0.000 |
Why?
|
| Spectrum Analysis | 1 | 1969 | 119 | 0.000 |
Why?
|
| Cricetinae | 1 | 1970 | 532 | 0.000 |
Why?
|
| Epinephrine | 1 | 1969 | 92 | 0.000 |
Why?
|
| Creatinine | 1 | 1970 | 293 | 0.000 |
Why?
|
| Duodenum | 1 | 1969 | 110 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1972 | 318 | 0.000 |
Why?
|
| Cell Membrane Permeability | 1 | 1969 | 121 | 0.000 |
Why?
|
| Dogs | 1 | 1969 | 634 | 0.000 |
Why?
|
| Fenoldopam | 1 | 1988 | 3 | 0.000 |
Why?
|
| Oxygen | 1 | 1973 | 769 | 0.000 |
Why?
|
| Water | 1 | 1970 | 307 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1968 | 99 | 0.000 |
Why?
|
| Water-Electrolyte Balance | 1 | 1968 | 68 | 0.000 |
Why?
|
| Hyperthyroidism | 1 | 1968 | 76 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1969 | 296 | 0.000 |
Why?
|
| Chlorides | 1 | 1968 | 101 | 0.000 |
Why?
|
| Hematocrit | 2 | 1979 | 66 | 0.000 |
Why?
|
| Potassium | 1 | 1968 | 232 | 0.000 |
Why?
|
| Physical Exertion | 1 | 1966 | 38 | 0.000 |
Why?
|
| Iron Isotopes | 1 | 1966 | 1 | 0.000 |
Why?
|
| Mental Status Schedule | 1 | 1986 | 27 | 0.000 |
Why?
|
| Acid Phosphatase | 1 | 1985 | 28 | 0.000 |
Why?
|
| Calcium, Dietary | 2 | 1980 | 68 | 0.000 |
Why?
|
| Castration | 1 | 1985 | 36 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1985 | 109 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 1972 | 797 | 0.000 |
Why?
|
| Blood Proteins | 2 | 1979 | 145 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1970 | 824 | 0.000 |
Why?
|
| Hepatectomy | 1 | 1966 | 177 | 0.000 |
Why?
|
| Blood Volume | 2 | 1973 | 42 | 0.000 |
Why?
|
| Dental Care | 1 | 1983 | 12 | 0.000 |
Why?
|
| Mitral Valve Prolapse | 1 | 1983 | 18 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1966 | 493 | 0.000 |
Why?
|
| Bone Neoplasms | 1 | 1985 | 313 | 0.000 |
Why?
|
| Iodine | 2 | 1970 | 43 | 0.000 |
Why?
|
| Sodium Pertechnetate Tc 99m | 1 | 1982 | 1 | 0.000 |
Why?
|
| Bronchial Neoplasms | 1 | 1982 | 7 | 0.000 |
Why?
|
| Hypothyroidism | 1 | 1984 | 275 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1992 | 2544 | 0.000 |
Why?
|
| Thyroxine | 2 | 1975 | 386 | 0.000 |
Why?
|
| Metiamide | 1 | 1979 | 1 | 0.000 |
Why?
|
| Atropine | 1 | 1979 | 53 | 0.000 |
Why?
|
| Bacteria | 1 | 1983 | 509 | 0.000 |
Why?
|
| Protein Binding | 2 | 1975 | 1534 | 0.000 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1977 | 71 | 0.000 |
Why?
|
| Parity | 1 | 1977 | 97 | 0.000 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1977 | 107 | 0.000 |
Why?
|
| Blood Volume Determination | 1 | 1955 | 13 | 0.000 |
Why?
|
| Microsomes | 1 | 1975 | 32 | 0.000 |
Why?
|
| Albumins | 1 | 1955 | 123 | 0.000 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1975 | 193 | 0.000 |
Why?
|
| Acne Vulgaris | 1 | 1975 | 33 | 0.000 |
Why?
|
| Thymus Gland | 1 | 1975 | 196 | 0.000 |
Why?
|
| Conjunctiva | 1 | 1973 | 16 | 0.000 |
Why?
|
| Immune Sera | 1 | 1973 | 48 | 0.000 |
Why?
|
| Central Venous Pressure | 1 | 1973 | 27 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1973 | 57 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1973 | 128 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1973 | 163 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1973 | 97 | 0.000 |
Why?
|
| Pulmonary Circulation | 1 | 1973 | 92 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1973 | 141 | 0.000 |
Why?
|
| Eye Diseases | 1 | 1973 | 58 | 0.000 |
Why?
|
| Chickens | 1 | 1973 | 206 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1973 | 203 | 0.000 |
Why?
|
| Arteries | 1 | 1973 | 171 | 0.000 |
Why?
|
| Pennsylvania | 1 | 1972 | 103 | 0.000 |
Why?
|
| Theophylline | 1 | 1971 | 34 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1970 | 131 | 0.000 |
Why?
|
| Femur | 1 | 1970 | 107 | 0.000 |
Why?
|
| Sports | 1 | 1966 | 40 | 0.000 |
Why?
|